6505--Hydralazine Hcl Injections Award - Hikma Pharmaceuticals
Justification · United States of America
Source: SAM.gov
This acquisition did not provide for full and open competition in accordance with FAR 6.302-7. While this acquisition did not provide for full and open competition, the solicitation was posted to SAM.gov and all offerors of U.S.-made product were considered. See the attached justification document for details.
- Status
- Closed
- Sector
- Residential, Commercial, Manufacturing (Industrial)
- Location
- United States of America
- Updated
- 3 Nov 2026
- Source
- SAM.gov
ConstructChat
Ask ConstructChat about 6505--Hydralazine Hcl Injections Award - Hikma Pharmaceuticals
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | justification |
Taiyo status | Closed |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | This acquisition did not provide for full and open competition in accordance with FAR 6.302-7. While this acquisition did not provide for full and open competition, the solicitation was posted to SAM.gov and all offerors of U.S.-made product were considered. See the attached justification document for details. |
Original sector | Not Identified |
Budget |
Location
Country | United States of America (USA) |
Source
Source | SAM.gov |
URL |
More Details
Record type | Tender |
Sector | Residential, Commercial, Manufacturing (Industrial) |
Article published date | 2025-11-22 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender